TPST

Tempest Therapeutics Inc

NASDAQ: TPST · HEALTHCARE · BIOTECHNOLOGY

$0.89

+2.46% today

Updated 2026-07-29

Market cap

$14.93M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-5.71

Dividend yield

—

52W range

$1 – $12

Volume

0.2M

Market cap

$14.93M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-5.71

Dividend yield

—

52W range

$1 – $12

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

2.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-23.6

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$11.00

+1132.63%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -23.63 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-7.60M

- Debt/equity 9.55x — high leverage

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-35.71M	$-29.49M	$-41.84M	$-26.26M	$-27.70M
EPS	—	—	—	—	$-5.71
Free cash flow	$-31.63M	$-27.53M	$-33.46M	$-26.82M	$-7.60M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TPST	$14.93M	17	4.3	3.0	5.0	2.5	—	Avoid
LLY	$1.02T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$615.36B	57	4.7	8.5	4.3	6.0	—	Buy
ABBV	$447.53B	63	4.0	8.0	4.7	5.0	-78.83%	Buy
UNH	$391.69B	62	7.3	5.5	4.0	6.0	-30.51%	Buy
MRK	$307.25B	50	3.3	8.0	2.7	5.0	-62.28%	Hold

Smart narrative

Tempest Therapeutics Inc trades at $0.89. Our Smart Value Score of 17/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -23.63, it sits in the distress.

Frequently asked questions

What is Tempest Therapeutics Inc's stock price?

Tempest Therapeutics Inc (TPST) trades at $0.89.

Is Tempest Therapeutics Inc overvalued?

Tempest Therapeutics Inc carries a Smart Value Score of 17/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Tempest Therapeutics Inc (TPST)?

The 12-month analyst consensus target is $11.00, about 1132.6% above the current $0.89. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Tempest Therapeutics Inc's Altman Z-Score is -23.63, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-203.60%

Beta-1.71

50D MA$1.29

200D MA$3.39

Shares out0.02B

Float0.01B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

TPST vs LLY →TPST vs JNJ →TPST vs ABBV →Stock screener →